rs1877316

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002401.5(MAP3K3):​c.872-24C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 1,600,324 control chromosomes in the GnomAD database, including 56,831 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 6010 hom., cov: 32)
Exomes 𝑓: 0.26 ( 50821 hom. )

Consequence

MAP3K3
NM_002401.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -5.31

Publications

18 publications found
Variant links:
Genes affected
MAP3K3 (HGNC:6855): (mitogen-activated protein kinase kinase kinase 3) This gene product is a 626-amino acid polypeptide that is 96.5% identical to mouse Mekk3. Its catalytic domain is closely related to those of several other kinases, including mouse Mekk2, tobacco NPK, and yeast Ste11. Northern blot analysis revealed a 4.6-kb transcript that appears to be ubiquitously expressed. This protein directly regulates the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by activating SEK and MEK1/2 respectively; it does not regulate the p38 pathway. In cotransfection assays, it enhanced transcription from a nuclear factor kappa-B (NFKB)-dependent reporter gene, consistent with a role in the SAPK pathway. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]
STRADA (HGNC:30172): (STE20 related adaptor alpha) The protein encoded by this gene contains a STE20-like kinase domain, but lacks several residues that are critical for catalytic activity, so it is termed a 'pseudokinase'. The protein forms a heterotrimeric complex with serine/threonine kinase 11 (STK11, also known as LKB1) and the scaffolding protein calcium binding protein 39 (CAB39, also known as MO25). The protein activates STK11 leading to the phosphorylation of both proteins and excluding STK11 from the nucleus. The protein is necessary for STK11-induced G1 cell cycle arrest. A mutation in this gene has been shown to result in polyhydramnios, megalencephaly, and symptomatic epilepsy (PMSE) syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their full-length nature is not known. [provided by RefSeq, Sep 2009]
STRADA Gene-Disease associations (from GenCC):
  • polyhydramnios, megalencephaly, and symptomatic epilepsy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 17-63689520-C-A is Benign according to our data. Variant chr17-63689520-C-A is described in ClinVar as Benign. ClinVar VariationId is 1248554.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.341 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002401.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K3
NM_002401.5
MANE Select
c.872-24C>A
intron
N/ANP_002392.2
MAP3K3
NM_203351.3
c.965-24C>A
intron
N/ANP_976226.1Q99759-2
MAP3K3
NM_001363768.2
c.953-24C>A
intron
N/ANP_001350697.1J3QRB6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K3
ENST00000361733.8
TSL:1 MANE Select
c.872-24C>A
intron
N/AENSP00000354485.4Q99759-1
MAP3K3
ENST00000361357.7
TSL:1
c.965-24C>A
intron
N/AENSP00000354927.3Q99759-2
MAP3K3
ENST00000579585.5
TSL:1
c.965-24C>A
intron
N/AENSP00000461988.1Q99759-2

Frequencies

GnomAD3 genomes
AF:
0.273
AC:
41499
AN:
151972
Hom.:
5997
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.345
Gnomad AMI
AF:
0.269
Gnomad AMR
AF:
0.207
Gnomad ASJ
AF:
0.271
Gnomad EAS
AF:
0.0553
Gnomad SAS
AF:
0.165
Gnomad FIN
AF:
0.204
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.279
Gnomad OTH
AF:
0.270
GnomAD2 exomes
AF:
0.235
AC:
55516
AN:
235772
AF XY:
0.234
show subpopulations
Gnomad AFR exome
AF:
0.347
Gnomad AMR exome
AF:
0.200
Gnomad ASJ exome
AF:
0.271
Gnomad EAS exome
AF:
0.0467
Gnomad FIN exome
AF:
0.219
Gnomad NFE exome
AF:
0.279
Gnomad OTH exome
AF:
0.244
GnomAD4 exome
AF:
0.260
AC:
376992
AN:
1448232
Hom.:
50821
Cov.:
30
AF XY:
0.258
AC XY:
185748
AN XY:
719230
show subpopulations
African (AFR)
AF:
0.346
AC:
11485
AN:
33218
American (AMR)
AF:
0.203
AC:
8887
AN:
43750
Ashkenazi Jewish (ASJ)
AF:
0.270
AC:
6918
AN:
25586
East Asian (EAS)
AF:
0.0507
AC:
1992
AN:
39304
South Asian (SAS)
AF:
0.177
AC:
14956
AN:
84352
European-Finnish (FIN)
AF:
0.224
AC:
11738
AN:
52366
Middle Eastern (MID)
AF:
0.287
AC:
1641
AN:
5720
European-Non Finnish (NFE)
AF:
0.276
AC:
304708
AN:
1104064
Other (OTH)
AF:
0.245
AC:
14667
AN:
59872
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
14632
29264
43896
58528
73160
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10028
20056
30084
40112
50140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.273
AC:
41539
AN:
152092
Hom.:
6010
Cov.:
32
AF XY:
0.267
AC XY:
19817
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.345
AC:
14314
AN:
41456
American (AMR)
AF:
0.206
AC:
3156
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.271
AC:
942
AN:
3472
East Asian (EAS)
AF:
0.0554
AC:
287
AN:
5178
South Asian (SAS)
AF:
0.163
AC:
788
AN:
4828
European-Finnish (FIN)
AF:
0.204
AC:
2163
AN:
10584
Middle Eastern (MID)
AF:
0.364
AC:
107
AN:
294
European-Non Finnish (NFE)
AF:
0.279
AC:
18974
AN:
67954
Other (OTH)
AF:
0.267
AC:
563
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1491
2982
4473
5964
7455
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.265
Hom.:
7202
Bravo
AF:
0.275
Asia WGS
AF:
0.137
AC:
478
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.0020
DANN
Benign
0.88
PhyloP100
-5.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1877316; hg19: chr17-61766880; COSMIC: COSV107464881; COSMIC: COSV107464881; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.